IP Library Patent Application 13903304
Patent Application
App. No. 13/903,304

Microspheres Including Oxidized Cellulose

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/903,304
Abstract

A process for forming microspheres is disclosed. The process includes: forming a first plurality microspheres comprising at least one bioactive agent and modified cellulose; contacting the first plurality of microspheres with a solution of a biodegradable polymer to form a discontinuous phase liquid; contacting the discontinuous phase liquid with a continuous phase liquid to form an emulsion; and extracting a second plurality of microspheres from the emulsion, the second plurality of microspheres comprising the first plurality of microspheres.

Claims (35)

1 . A process for forming microspheres comprising:

forming a first plurality microspheres comprising at least one bioactive agent and modified cellulose;

contacting the first plurality of microspheres with a solution of a biodegradable polymer to form a discontinuous phase liquid;

contacting the discontinuous phase liquid with a continuous phase liquid to form an emulsion; and

extracting a second plurality of microspheres from the emulsion, the second plurality of microspheres comprising the first plurality of microspheres.

2 . The process according to claim 1 , wherein the at least one bioactive agent is selected from the group consisting of a hydrophilic bioactive agent, a protein therapeutic, a biologic, and combinations thereof.

3 . The process according to claim 2 , wherein the biodegradable polymer is an aliphatic polyester.

4 . The process according to claim 3 , wherein the aliphatic polyester is selected from the group consisting of polylactide, polylactide-co-glycolide, polylactide-polycaprolactone, and combinations thereof.

5 . The process according to claim 1 , wherein the continuous phase liquid comprises at least one emulsifier and water.

6 . The process according to claim 1 , further comprising:

contacting the second plurality of microspheres with a modified cellulose solution to form a second discontinuous phase liquid;

contacting the second discontinuous phase liquid with a second continuous phase liquid to form a second emulsion; and

extracting a third plurality of microspheres from the second emulsion, the third plurality of microspheres comprising the second plurality of microspheres.

7 . A process for forming microspheres comprising:

forming a first plurality microspheres comprising a biodegradable polymer;

contacting the first plurality of microspheres with a modified cellulose solution to form a discontinuous phase liquid;

contacting the discontinuous phase liquid with a continuous phase liquid to form an emulsion; and

extracting a second plurality of microspheres from the emulsion, the second plurality of microspheres comprising the first plurality of microspheres.

8 . The process according to claim 7 , wherein at least one of the first plurality of microspheres or the modified cellulose solution comprises at least one bioactive agent.

9 . The process according to claim 8 , wherein the at least one bioactive agent is selected from the group consisting of a hydrophilic bioactive agent, a protein therapeutic, a biologic, and combinations thereof.

10 . The process according to claim 7 , wherein the biodegradable polymer is an aliphatic polyester.

11 . The process according to claim 10 , wherein the aliphatic polyester is selected from the group consisting of polylactide, polylactide-co-glycolide, polylactide-polycaprolactone, and combinations thereof.

12 . The process according to claim 7 , comprising:

contacting the second plurality of microspheres with a second solution of a biodegradable polymer to form a second discontinuous phase liquid;

contacting the second discontinuous phase liquid with a second continuous phase liquid to form a second emulsion; and

extracting a third plurality of microspheres from the second emulsion, the third plurality of microspheres comprising the second plurality of microspheres.

13 . A microsphere comprising:

a first biodegradable polymer encapsulating at least one additional microsphere, the at least one additional microsphere comprising a second biodegradable polymer and at least one bioactive agent, wherein the first biodegradable polymer and the second biodegradable polymer are different and at least one of the first biodegradable polymer or the second biodegradable polymer is modified cellulose.

14 . The microsphere according to claim 13 , wherein the first biodegradable polymer encapsulating the at least one additional microsphere is further encapsulated in a third microsphere formed of the second biodegradable polymer.

15 . The microsphere according to claim 13 , wherein at least one of the first biodegradable polymer or the second biodegradable polymer is an aliphatic polyester.

16 . The microsphere according to claim 15 , wherein the aliphatic polyester is selected from the group consisting of polylactide, polylactide-co-glycolide, polylactide-polycaprolactone, and combinations thereof.

17 . The microsphere according to claim 13 , wherein the first biodegradable polymer is selected from the group consisting of polylactide, polylactide-co-glycolide, polylactide-polycaprolactone, and combinations thereof and the second biodegradable polymer is modified cellulose.

18 . The microsphere according to claim 13 , wherein the first biodegradable polymer is modified cellulose and the second biodegradable polymer is selected from the group consisting of polylactide, polylactide-co-glycolide, polylactide-polycaprolactone, and combinations thereof.

19 . The microsphere according to claim 13 , further comprising at least one additional bioactive agent.

20 . The microsphere according to claim 19 , wherein the at least one additional bioactive agent is selected from the group consisting of a hydrophilic bioactive agent, a protein therapeutic, a biologic, and combinations thereof and the first biodegradable polymer is modified cellulose.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2014
From: CONFLUENT SURGICAL, INC.
To: COVIDIEN LP
Reel/Frame 031957/0415 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2013
From: BLASKOVICH, PHILLIP; OHRI, RACHIT; PHAM, LAN
To: CONFLUENT SURGICAL, INC.
Reel/Frame 031007/0482 →